论文部分内容阅读
目的探讨静脉溶栓治疗急性心肌梗死的临床疗效。方法回顾性分析栾川县人民医院收治的38例急性心肌梗死患者的临床资料,在常规治疗的基础上均采用尿激酶静脉溶栓治疗。结果 38例患者中31例溶栓成功,再通率达76.31%,6例溶栓失败发生泵衰竭转上级医院,住院期间死亡1例,病死率为2.6%。结论静脉溶栓可有效治疗急性心肌梗死,降低了病死率和致残率,减少了心肌损伤,实现了血管功能重建,且患者治疗的时间越早,血管再通率就越高。
Objective To investigate the clinical efficacy of intravenous thrombolysis in the treatment of acute myocardial infarction. Methods The clinical data of 38 patients with acute myocardial infarction admitted to Luanchuan People’s Hospital were retrospectively analyzed. Thrombolytic therapy with urokinase was used on the basis of routine treatment. Results Among the 38 patients, 31 cases were succeeded in thrombolysis, with a recurrence rate of 76.31%. Six cases failed in failure of thrombolysis and went to the superior hospital. One patient died during hospitalization and the case fatality rate was 2.6%. Conclusion Intravenous thrombolysis can effectively treat acute myocardial infarction, reduce mortality and disability, reduce myocardial damage, and achieve vascular reconstruction. The earlier the treatment is, the higher the recanalization rate is.